These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 83968)

  • 1. A quantitative assay for tumor antigen based on inhibition of cytotoxicity of sensitized lymphocytes.
    Huber S; Lucas ZJ
    Int J Cancer; 1979 Feb; 23(2):224-32. PubMed ID: 83968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.
    Christensen ND; Kreider JW; Bartlett GL; Horetsky RL
    Cell Immunol; 1986 Feb; 97(2):433-45. PubMed ID: 3091274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to a mammary adenocarcinoma. V. Sera from tumor-bearing rats contain multiple factors blocking cell-mediated cytotoxicity.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2485-9. PubMed ID: 722081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor lymphokine produced by rat T-cells in response to syngeneic mammary adenocarcinoma 13762A.
    Christensen ND; Kreider JW; Horetsky RL
    Cancer Res; 1988 Feb; 48(4):943-9. PubMed ID: 2962735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1277-81. PubMed ID: 51887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of lymphocyte stimulation by intact tumor-cell and solubilized tumor antigen.
    Dean JH; McCoy JL; Lewis D; Appella E; Law LW
    Int J Cancer; 1975 Sep; 16(3):465-75. PubMed ID: 51834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to a syngeneic mammary adenocarcinoma. I. Comparison of kinetics of tumor cell growth and cytotoxic responses in syngeneic and allogeneic rats.
    Fortner GW; Kuperman O; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1269-76. PubMed ID: 1080776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor antigen extracts stimulate cytotoxicity against unrelated target cells.
    Lopez DM; Sigel MM
    Int J Cancer; 1976 Dec; 18(6):808-12. PubMed ID: 992908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-2 private specificity of in vivo-sensitized lymphocytes studied by adsorption on fibroblast monolayers.
    Jorgensen PN; Güttler F; Rubin B
    Scand J Immunol; 1975; 4(4):383-9. PubMed ID: 52890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target cell - substratum interaction. I. Effect of primed lymphocytes on a rat mammary adenocarcinoma tumor cell line.
    David GS; Wiglesworgh CM
    Immunol Commun; 1978; 7(3):337-52. PubMed ID: 77840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.
    Boyer CM; Kreider JW; Bartlett GL
    Cancer Res; 1981 Jun; 41(6):2394-400. PubMed ID: 6972251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to a mammary adenocarcinoma. VI. Blocking of tumor-specific cell-mediated cytotoxicity by antibodies to the cytotoxic lymphocyte.
    Huber SA; Lucas ZJ
    J Immunol; 1978 Dec; 121(6):2490-6. PubMed ID: 309904
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune response to a syngeneic mammary adenocarcinoma. III. Development of memory and suppressor functions modulating cellular cytotoxicity.
    Kuperman O; Fortner GW; Lucas ZJ
    J Immunol; 1975 Nov; 115(5):1282-7. PubMed ID: 1176776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD; Padmanabhan R; Lopez DM
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.